Recent developments highlight Reliance Global Group's growth in insurance policy writings, strategic acquisitions, capital raises, and debt reduction efforts.

• Reliance Global Group reported a 72% increase in health insurance policies written through RELI Exchange during the 2025 open enrollment period [N2].
• The company announced a 36% year-over-year increase in personal lines property and casualty written premium through RELI Exchange [N3].
• In January 2026, Reliance Global Group completed a $2 million public offering to raise capital [N5].
• The company acquired an initial 8% equity interest in Enquantum Ltd., an AI breath diagnostics firm, with plans to increase ownership to 51% subject to milestones [N6].
• Reliance Global Group reduced its long-term debt by approximately 50% to enhance financial flexibility as of mid-2025 [N7].
• The company reported strong preliminary Q1 2025 financial results for Spetner Associates, Inc. amid acquisition progress [N8].
• Reliance Global Group is executing a transformative OneFirm Strategy to unify operations and drive growth [N1].

Reliance Global Group has demonstrated growth in its core insurance brokerage business, with significant increases in health insurance policies and personal lines premiums written through its RELI Exchange platform. The company's strategic acquisition of an equity stake in Enquantum Ltd., an AI breath diagnostics firm, signals diversification into innovative healthcare technology sectors. The reduction of long-term debt by approximately 50% enhances financial flexibility to support growth initiatives. The launch of new services such as RELI Auto Leasing expands revenue opportunities for agency partners. The company's OneFirm Strategy reflects a transformative approach to unify operations and drive efficiency. These factors collectively indicate active execution of growth and innovation strategies.

The company reported a net loss of approximately $6.99 million for the full year 2025, indicating ongoing profitability challenges. The insurance brokerage and InsurTech sectors are competitive, with risks related to platform adoption, regulatory changes, and integration of acquisitions. The milestone-based acquisition structure for Enquantum Ltd. introduces execution risk related to meeting operational and commercialization targets. The company's reliance on capital raises and public offerings to fund operations may dilute existing shareholders. Settlement agreements related to prior stock purchase transactions suggest potential governance and legal complexities. Maintaining growth momentum and achieving profitability remain key challenges.

Reliance Global Group's moat is anchored in its integrated InsurTech platform, RELI Exchange, which facilitates insurance policy sales and premium writings, providing a scalable digital distribution channel. The company's ability to increase health insurance policies and personal lines premiums through this platform demonstrates operational leverage and customer acquisition capabilities. Strategic acquisitions and investments, such as the planned majority stake in Enquantum Ltd., indicate a focus on innovation and diversification into AI-driven diagnostics, potentially enhancing competitive differentiation. The company's efforts to reduce long-term debt and maintain strong liquidity ratios support financial flexibility to invest in growth initiatives. However, the insurance brokerage industry is competitive, and the company's moat depends on continued platform adoption, successful integration of acquisitions, and execution of its OneFirm Strategy.

• Profitability Risk: The company reported a net loss of approximately $6.99 million for the full year 2025, indicating challenges in achieving profitability.
• Execution Risk on Acquisitions: The milestone-based acquisition of Enquantum Ltd. depends on meeting operational and commercialization milestones, which introduces execution risk.
• Competitive Industry: The insurance brokerage and InsurTech sectors are competitive, with risks from market adoption, pricing pressure, and regulatory changes.
• Capital Raising and Dilution: The company has conducted multiple public offerings and private placements, which may dilute existing shareholders and depend on market conditions.
• Legal and Governance Risks: Settlement agreements related to prior stock purchase transactions indicate potential governance and legal complexities that could impact operations.

• Reliance Global Group, Inc. is a Florida corporation listed on the NASDAQ Capital Market under the ticker EZRA with common stock and Series A warrants.
• The company operates in the insurance brokerage and related services sector, with a focus on health insurance and personal lines property and casualty insurance.
• Reliance Global Group operates the RELI Exchange, an InsurTech platform facilitating insurance policy sales and premium writings.
• During the 2025 open enrollment period, the company reported a 72% increase in health insurance policies written through RELI Exchange compared to the prior year.
• The company also announced a 36% year-over-year increase in personal lines property and casualty written premium through RELI Exchange.
• Reliance Global Group completed a $2 million public offering in January 2026.
• The company has engaged in strategic acquisitions and investments, including acquiring an initial 8% equity interest in Enquantum Ltd., an Israeli AI breath diagnostics firm, with plans to increase ownership to 51% subject to milestones.
• The CEO, Ezra Beyman, was appointed to the board of directors of Enquantum as part of the governance provisions of the acquisition.
• Reliance Global Group has reduced its long-term debt by approximately 50% to enhance financial flexibility as of mid-2025.
• The company reported preliminary strong Q1 2025 financial results for Spetner Associates, Inc., amid acquisition progress.
• Reliance Global Group signed a letter of intent to sell Fortman Insurance Agency for $5 million in mid-2025.
• The company launched RELI Auto Leasing to enhance revenue opportunities for agency partners in early 2025.
• The company reported full year 2025 revenue of approximately $12.43 million and a net loss of approximately $6.99 million, with basic and diluted EPS of -1.28 USD per share as of December 31, 2025.
• Liquidity ratios as of December 31, 2025, include a current ratio of 1.78 and a cash ratio of 4.18, with cash and equivalents of approximately $10 million and current liabilities of approximately $2.4 million.
• The company has a history of equity offerings and private placements to raise capital, including a private placement expected to raise approximately $2.5 million in mid-2025.
• The company has a Compensation Recovery Policy (Clawback Policy) dated November 13, 2023, filed as an exhibit in its 10-K/A.
• The company is not classified as an emerging growth company and is a smaller reporting company under SEC definitions.
• The company has a 2019 Equity Incentive Plan and a 2024 Omnibus Incentive Plan for employee compensation.
• The company has entered into settlement agreements related to prior stock purchase transactions to resolve claims and enhance governance.
• The company has publicly disclosed its business strategy under the 'OneFirm Strategy' and has communicated transformative initiatives in 2025 and early 2026.